Two charities have agreed to pay several million dollars to GlaxoSmithKline to help finance the development of new medicines for infectious diseases.

The Medicines for Malaria Venture and the TB Alliance, two non-profit drug development partnerships substantially supported by the Bill & Melinda Gates Foundation, announced expanded funding to GSK on Thursday.